What is BCI? What types? What technologies? What are your applications? Is there a market? These issues are addressed in the first part. The synthesis of research on the original development since 1995 of the BrainGate Brain-Computer Interface is included in the second part. In May 2009, the FDA provided a new IDE for the BrainGate2 Neural Interface System pilot clinical trial. In the third part, this development is recorded, whose last result was the one published in the Lancet.
How close are we to controlling with our brain external objects or our own previously immobilized body? Not yet so close. By September 2021 it is planned to collect primary data.
Read: Brain Computer Interface. The Case of BrainGate2 Neural Interface S... (134 pages)